The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations

December 17, 2025 updated by: University of Copenhagen

The CPH-MBD Cohort - Substudy on Dietary History

The aim of the study is to assess the association between the calcium and phosphorus balance and the stage of kidney disease measured by creatinine clearence in patients with chronic kidney disease stage 4 and 5. The balance is measured a measurement between the recorded diatery intake and the urinary excretion. Additionally a comparison between image based diatery accessment and weighted records will be measured

Study Overview

Detailed Description

All participants will be asked to take photos of all the food and fluids they consume during 24 hours. Additionally participants will be offered to weight their food and fluid for 3 days.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jens Rikardt Andersen, MD, MPA
  • Phone Number: 004523346654
  • Email: jra@nexs.ku.dk

Study Contact Backup

Study Locations

      • Herlev, Denmark, 2730
        • Recruiting
        • Herlev Hospital, Dept Nephrology
        • Contact:
        • Sub-Investigator:
          • Julian A Bluming, RD
    • Capital Region
      • Herlev, Capital Region, Denmark, 2730
        • Active, not recruiting
        • Copenhagen University Hospital - Herlev

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with chronic kidney disease stage 4-5

Description

Inclusion Criteria:

  • A glomerular filtration rate of <30 ml ml/min/1.73m2
  • 18 years and above

Exclusion Criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of diatery photograph method with weighted records.
Time Frame: 3 days
The intake of calcium and phosphate assesed by the 24 hour photos and the 72 hour weighing of food and fluid items will be compared.
3 days
Calcium and phosphate balance in relation to the stage of kidney disease
Time Frame: 3 days
Measured by the diatery intake of calcium and phosphate in relation to the urinary calcium and phosphate excretion
3 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary Calcium
Time Frame: 3 days
mmol/day
3 days
Urinary phosphate
Time Frame: 3 days
mmol/day
3 days
Calcium intake total and the distribution of vegetarian and animal sources
Time Frame: 3 days
mg/day
3 days
Phosphate intake total and the distribution of vegetarian and animal sources
Time Frame: 3 days
mg/day
3 days
sodium intake total and the distribution of vegetarian and animal sources
Time Frame: 3 days
mg/day
3 days
Energy intake
Time Frame: 3 days
Kcal/day
3 days
Protein intake
Time Frame: 3 days
g/day
3 days
Fat intake
Time Frame: 3 days
g/day
3 days
Fluid intake
Time Frame: 3 days
ml/day
3 days
Plasma phosphate
Time Frame: 3 days
mmol/l
3 days
Plasma calcium
Time Frame: 3 days
mmol/l
3 days
Urinary creatinine
Time Frame: 3 days
mmol/day
3 days
Urinary urea
Time Frame: 3 days
mmol/day
3 days
Urinary sodium
Time Frame: 3 days
mmol/day
3 days
Plasma FGF23
Time Frame: 3 days
mmol/l
3 days
P-calcium P- phosphate product
Time Frame: 3 days
Can be calculated by multiplying plasma calcium and plasma phosphate
3 days
plasma 25-OH-Vitamin D
Time Frame: 3 days
nmol/l
3 days
plasma PTH
Time Frame: 3 days
pmol/l
3 days
Plasma Albumin
Time Frame: 3 days
g/dl
3 days
eGFR
Time Frame: 3 days
ml/min/1.73m2
3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jens Rikardt Andersen, MD, MPA, Assoc Prof, University of Copenhagen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2025

Primary Completion (Estimated)

May 15, 2026

Study Completion (Estimated)

May 15, 2029

Study Registration Dates

First Submitted

December 17, 2025

First Submitted That Met QC Criteria

December 17, 2025

First Posted (Actual)

December 31, 2025

Study Record Updates

Last Update Posted (Actual)

December 31, 2025

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

December 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on CKD

Subscribe